Blog
This High-Yield Dividend Stock Has Stomped on the Gas in 2022
Williams (NYSE: WMB) is having a big year. The natural gas pipeline giant has gone on a shopping spree and recently unveiled its third acquisition to enhance its gas pipeline network. These deals
2 Top Buffett Stocks to Buy and Hold for the Long Haul
As Berkshire Hathaway CEO Warren Buffett has famously said, it often pays to be greedy when others are fearful and fearful when others are greedy -- and there's certainly no shortage of fear shaping
Dogecoin: The Ultimate Blend of Absurdity and Value?
On Dec. 6, 2013, Billy Markus and Jackson Palmer decided to combine their love of the internet's most beloved Shiba Inu (aka "Doge") with their passion for cryptocurrency. And thus, Dogecoin
Warren Buffett Bought Boatloads of These 2 Stocks in 2022
The 92-year-old Warren Buffett and his company Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) have been beating the market for decades, standing strong even through multiple recessions. That's why
3 Tempting Mistakes to Avoid if There's a New Bull Market in 2023
Bull markets are times of burgeoning opportunity, and with opportunity comes risk that's easier to sweep under the rug than to account for soberly. Especially after a brutal 2022, investors are apt
Investors Roundly Rejected Pubmatic Stock in 2022. Will It Be a Buy in 2023?
Investors following Pubmatic (NASDAQ: PUBM) may have predicted the digital advertiser would eventually run into a roadblock in 2022. Once the Federal Reserve began to rapidly raise interest rates at
Retiring in 2023? 3 Steps to Take Before 2022 Ends
The finish line is in sight. You're ready to finally leave the workforce behind to devote more time to what you enjoy. But quitting your job doesn't mean you can ignore your finances completely. If
No, Tesla Stock Is Not Cheap
Based on the average analyst estimate for 2023 earnings, shares of electric-vehicle (EV) manufacturer Tesla (NASDAQ: TSLA) are cheaper than they've ever been. Tesla trades for just 28 times forward
Oracle's Cash Flows Are Soaring Despite Macroeconomic Headwinds
Oracle's (NYSE: ORCL) cash flow from operations soared in its most recent quarter. Investors feared a slowdown as macroeconomic headwinds gained momentum. The company is digesting a
3 Secrets to Making Money in the Stock Market -- Even During a Recession
It's been a difficult year for investors, and many are concerned that the worst is yet to come.
To be clear, nobody knows for certain what's on the horizon, though some experts are predicting a
1 Cryptocurrency I'd Buy Right Now
By any standard, 2022 has not been a good year for Cardano (CRYPTO: ADA), which is currently trading for just $0.31. The crypto is down nearly 77% year to date, and 90% from its all-time-high of
Block May Look Cheap, but I'm Not Buying
Fintech as a sector hasn't fared well in 2022. Cathie Wood's Ark Invest Fintech Innovation ETF, for example, is down 62% in 2022. Fintech isn't limited to unprofitable tech stocks in the financial
Is Lucid Stock a Buy?
I'm bullish on electric-vehicle (EV) stocks, and if you're reading this, it's likely that you could be of a similar persuasion.
There's good reason to be optimistic. For one, nearly 60% of new
2 Reasons Your 2023 Social Security COLA Could Hold Up Better Than Expected
In October, seniors on Social Security got some seemingly good news -- their benefits will be rising by 8.7% in 2023. That increase well outpaces the 5.9% cost-of-living adjustment (COLA)
Is Nvidia's Move Into Software a Good Idea?
In today's video, Jose Najarro and Nick Rossolillo discuss Nvidia (NASDAQ: NVDA) and their thoughts on why this could be an excellent move for the company's future. They also share some of their
Better Buy: Boeing or Hexcel?
The aerospace giant Boeing (NYSE: BA) or one of its key suppliers, Hexcel (NYSE: HXL), for 2023? It's an interesting question because the two companies share a common earnings driver: increasing
Is Warren Buffett's Berkshire Hathaway Stock a Buy Before the End of 2022?
This has been an exceptionally good year for shares of Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B). Warren Buffett's investment conglomerate is up over 3% with just a couple of weeks to go until
3 Stocks to Buy Right Now for Generational Wealth Creation
The stock market is full of beaten-down stocks, and even some of the best businesses have declined sharply. In this video, Certified Financial Planner® Matt Frankel shares three stocks that look
After Jumping 100%, Is Axsome a Buy Before 2023?
Axsome Therapeutics (NASDAQ: AXSM) has done something most other stocks haven't been able to do this year: It's beaten the bear market. The shares are heading for a 111% gain as the S&P 500 heads
How Does Amazon Make Money?
Everybody knows Amazon (NASDAQ: AMZN). It is one of the largest companies in the world, landing a top 5 spot whether you measure by revenue, market cap, or the number of employees.
As big as it
Better Buy: General Electric or Raytheon Technologies?
General Electric (NYSE: GE) or Raytheon Technologies (NYSE: RTX) for 2023? The two industrial giants are fierce rivals in commercial aerospace (they are the two leading players in aircraft engines)
Meme Stocks That Are Actually Solid Long-Term Picks
Meme stocks, popular with retail investors, can be good long-term investments if you ignore the hype around companies and look at their financials and long-term business prospects. There are a lot
Taiwan Semiconductor Has Another Epic Month in November 2022, but Will the Growth Last?
In today's video, Jose Najarro and Nick Rossolillo discuss Taiwan Semiconductor Manufacturing (NYSE: TSM) and a recent report by TrendForce that focuses on revenue expectations for the semiconductor
2 Growth Stocks Down 69% and 77% to Buy Right Now
Wins have been hard to come by for technology investors in 2022. A combination of high inflation, rising interest rates, additional macroeconomic headwinds, and company-specific pressures have
Why Pfizer Stock Is Riskier Than AbbVie
What in the world are investors thinking? AbbVie's (NYSE: ABBV) share price has soared more than 20% in 2022. But in a matter of weeks, the company's top-selling drug, Humira, faces competition from


